Navigation Links
HealthWarehouse.com Reports 38% Year-Over-Year Revenue Growth in the First Quarter 2012
Date:9/5/2012

CINCINNATI, Sept. 5, 2012 /PRNewswire/ -- HealthWarehouse.com, Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the first quarter ended March 31, 2012.

In the first quarter of 2012, the Company's quarterly net sales increased to $3,153,607 from $2,284,552, up 38% compared to the same period in 2011. 

Selling, general and administrative expenses (SG&A) increased by $730,780 in the first quarter of 2012 compared to the same period in 2011.  Net loss in the first quarter of 2012 increased to $1,550,312, as compared with a net loss of $1,071,279 for the same period in 2011. The increase in SG&A expenses and net loss was due primarily to the expansion of resources to handle growth of the Company's prescription sales.

"We are pleased with the growth we continue to see with our business," said Lalit Dhadphale, President and CEO of HealthWarehouse.com. "We remain focused on execution and are excited by the solid sales we've witnessed from the recent generic launches of Plavix® and Lipitor®. We expect this momentum to continue with the recent releases of generic Actos® and Singulair®. Additionally, we intend to take increasing market share over the next few quarters by expanding our sales channels and exceeding customer expectations."

About HealthWarehouse.com, Inc.

HealthWarehouse.com, Inc. (OTC: HEWA) is a trusted VIPPS-accredited retail mail-order pharmacy based in the Cincinnati area.  HealthWarehouse.com offers more than 300 prescription drugs for $3.50 with 100% FREE shipping and is a three-time consecutive winner of the BizRate Circle of Excellence Award for outstanding customer satisfaction and service. With a mission to provide affordable healthcare to every American by eliminating inefficiencies in the drug distribution chain, HealthWarehouse.com has become the leading online pharmacy in the United States. HealthWarehouse.com is licensed in all 50 states and DC, and only sells drugs which are FDA-approved and legal for sale in the United States.  Visit HealthWarehouse.com online at http://www.HealthWarehouse.com.

Actos® is a registered trademark of Takeda Pharmaceutical Company Limited.

Lipitor® is a registered trademark of Pfizer Corporation.

Plavix® is a registered trademark of Sanofi-Aventis.

Singulair® is a registered trademark of Merck & Co., Inc.


'/>"/>
SOURCE HealthWarehouse.com, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
2. HealthWarehouse.com Reports 82% Year-Over-Year Revenue Growth
3. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
5. MGC Diagnostics Corporation Reports Third Quarter Fiscal Year 2012 Operating Results
6. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
7. China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results
8. China Kanghui Holdings Reports Second Quarter 2012 Financial Results
9. Concord Medical Reports Second Quarter 2012 Financial Results
10. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
11. Organovo Reports Q2 2012 Financial Results, Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):